Belletti Alessandro, Jacobs Stephan, Affronti Giovanni, Mladenow Alexander, Landoni Giovanni, Falk Volkmar, Schoenrath Felix
Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy.
Department of Cardiothoracic and Vascular Surgery, Deutsches Herzzentrum Berlin, Berlin, Germany; DZHK (German Centre for Cardiovascular Research), Berlin, Germany.
J Cardiothorac Vasc Anesth. 2018 Dec;32(6):2528-2536. doi: 10.1053/j.jvca.2017.12.015. Epub 2017 Dec 11.
Patients with infective endocarditis undergoing cardiac surgery are a high-risk population. Few data on incidence and predictors of need for high-dose inotropic support in this setting are currently available.
Retrospective study.
Tertiary-care hospital.
Ninety consecutive patients undergoing cardiac surgery for infective endocarditis.
None.
Baseline, intraoperative and outcome data were collected. Stepwise multiple logistic regression analysis was performed to identify preoperative predictors of postoperative hemodynamic support. High-dose postoperative inotropic support was defined as inotropic score >10 (calculated as dobutamine dose (in µg/kg/min) + dopamine dose (in µg/kg/min) + (epinephrine dose [in µg/kg/min] × 100) + (norepinephrine dose [in µg/kg/min] × 100) + (milrinone dose [in µg/kg/min] × 10) + (vasopressin dose [in U/kg/min] × 10 000) + (levosimendan dose [in µg/kg/min] × 50) or need for mechanical circulatory support at intensive care unit admission. Postoperative high-dose inotropic or mechanical circulatory support was required in 57 cases (61%). Stepwise multiple logistic regression identified 5 variables independently associated with need for postoperative circulatory support: male sex (odds ratio [OR] = 10.9), surgery duration (OR for every minute increase = 1.01), impairment of kidney function (eGFR <60 mL/min/m - OR = 19), preoperative new-onset heart failure (defined by clinical, imaging and laboratory parameters - OR = 5.30), and low preoperative platelet count (for every 1×10/μl increase - OR = 0.99).
Patients undergoing cardiac surgery for infective endocarditis are at high risk for postoperative hemodynamic instability. Preoperative organ failure is an important determinant for postoperative hemodynamic instability.
接受心脏手术的感染性心内膜炎患者属于高危人群。目前关于此情况下高剂量血管活性药物支持的发生率及预测因素的数据较少。
回顾性研究。
三级医疗中心。
连续90例接受感染性心内膜炎心脏手术的患者。
无。
收集基线、术中及结局数据。进行逐步多因素逻辑回归分析以确定术后血流动力学支持的术前预测因素。术后高剂量血管活性药物支持定义为血管活性评分>10(计算方法为:多巴酚丁胺剂量[μg/kg/分钟]+多巴胺剂量[μg/kg/分钟]+(肾上腺素剂量[μg/kg/分钟]×100)+(去甲肾上腺素剂量[μg/kg/分钟]×100)+(米力农剂量[μg/kg/分钟]×10)+(血管加压素剂量[U/kg/分钟]×10000)+(左西孟旦剂量[μg/kg/分钟]×50))或在重症监护病房入院时需要机械循环支持。57例(61%)患者术后需要高剂量血管活性药物或机械循环支持。逐步多因素逻辑回归分析确定了5个与术后循环支持需求独立相关的变量:男性(比值比[OR]=10.9)、手术时间(每增加1分钟的OR=1.01)、肾功能损害(估算肾小球滤过率<60ml/min/㎡-OR=19)、术前新发心力衰竭(根据临床、影像学和实验室参数定义-OR=5.30)以及术前血小板计数低(每增加1×10⁹/μl-OR=0.99)。
接受感染性心内膜炎心脏手术的患者术后血流动力学不稳定风险高。术前器官功能衰竭是术后血流动力学不稳定的重要决定因素。